Anakinra Treatment: Uses, Dosage, and Side Effects Explained

Summary of Key Points

Anakinra is a prescription medication used to treat various inflammatory conditions, including rheumatoid arthritis, Still’s disease, and gout. It works by blocking specific proteins in the body that contribute to inflammation. Anakinra is often prescribed when other treatments have not been effective. Always consult a healthcare provider before starting or adjusting your dose. Our telemedicine providers are available to help manage your treatment plan.

Names of Medication

US Brand Name: Kineret

Generic Name: Anakinra

The generic name refers to the active ingredient, while the brand name is given by the manufacturer. In this article, the generic name will be listed in parentheses.

Pharmacologic Category

Interleukin-1 (IL-1) receptor antagonist

Anakinra Dosage

Anakinra is used to treat several inflammatory conditions, with dosing varying based on the condition. Always consult your doctor before adjusting your dose. If you need assistance, our telemedicine providers are here to help.

Anakinra for Rheumatoid Arthritis

Dosage: 100 mg injected under the skin once daily. Treatment is typically long-term.

Anakinra for Osteoarthritis

Dosage: 100 mg injected under the skin once daily. The treatment duration may vary depending on the severity of the condition.

Anakinra for Still’s Disease

Dosage: 1-2 mg/kg injected under the skin once daily, with a maximum dose of 100 mg per day. Treatment duration depends on the patient’s response.

Anakinra for Systemic Juvenile Idiopathic Arthritis

Dosage: 1-2 mg/kg injected under the skin once daily, with a maximum dose of 100 mg per day. Treatment is usually long-term.

Anakinra for Gout

Dosage: 100 mg injected under the skin once daily for 3 days. Treatment may be extended based on the severity of the flare-up.

Anakinra for Psoriatic Arthritis

Dosage: 100 mg injected under the skin once daily. Treatment is typically long-term.

Anakinra for Ankylosing Spondylitis

Dosage: 100 mg injected under the skin once daily. The treatment duration depends on the patient’s response.

Anakinra for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Dosage: 100 mg injected under the skin once daily. Treatment duration may vary based on the patient’s condition.

Anakinra for Familial Mediterranean Fever

Dosage: 1-2 mg/kg injected under the skin once daily, with a maximum dose of 100 mg per day. Treatment is usually long-term.

Anakinra for Cryopyrin-Associated Periodic Syndromes (CAPS)

Dosage: 1-2 mg/kg injected under the skin once daily, with a maximum dose of 100 mg per day. Treatment is typically long-term.

Dosage Forms and Strengths

Pre-filled syringe: 100 mg/0.67 mL

Administration Instructions for Anakinra Injection

Anakinra is administered as a subcutaneous injection. It’s important to rotate injection sites to avoid irritation. Common areas include the abdomen, thighs, or upper arms. Clean the injection site with an alcohol swab before administering the medication. Always follow your healthcare provider’s instructions on proper injection techniques. If you have questions or concerns, our telemedicine providers can assist you.

Anakinra Side Effects and Adverse Reactions

Like all medications, Anakinra may cause side effects. It’s important to be aware of these and contact your healthcare provider if you experience severe or persistent symptoms.

1. Injection site reactions: Redness, swelling, or pain at the injection site. These are common and usually mild.
2. Infections: Anakinra can increase the risk of infections, including upper respiratory infections. Contact your doctor if you develop a fever or other signs of infection.
3. Headache: Some patients may experience headaches while using Anakinra.
4. Nausea: Mild nausea may occur but is usually temporary.
5. Neutropenia: A decrease in white blood cells, which can increase the risk of infections. Your doctor may monitor your blood counts during treatment.

Contraindications for Anakinra Treatment

A contraindication is a specific condition where a medication should not be used because it may cause harm. For Anakinra, several contraindications must be considered before starting treatment.

1. Allergy to Anakinra or its components: If you have a known allergy to Anakinra or any of its ingredients, taking this medication could cause a serious allergic reaction, including symptoms like rash, swelling, or difficulty breathing.
2. Active infections: Anakinra can weaken your immune system, making it harder to fight infections. If you have an active infection, taking Anakinra could worsen it or make it harder to treat.
3. Low white blood cell count (neutropenia): Anakinra can lower your white blood cell count, which is essential for fighting infections. If you already have a low count, taking Anakinra could increase your risk of serious infections.

It’s crucial to discuss any medical conditions or concerns with your healthcare provider before starting Anakinra. If you have any of the above contraindications, your provider may recommend an alternative treatment. You can consult one of our telemedicine providers to determine the best course of action for your specific situation.

Drug to Drug Interactions with Anakinra

Some medications may interact with Anakinra, potentially reducing its effectiveness or increasing the risk of side effects. Inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. The following medications may interact with Anakinra:

1. TNF inhibitors: Medications like Etanercept (Enbrel), Adalimumab (Humira), and Infliximab (Remicade) should not be taken with Anakinra. Combining these medications can increase the risk of serious infections.
2. Live vaccines: Vaccines such as the MMR (measles, mumps, rubella) or Varicella (chickenpox) vaccines should not be given while taking Anakinra, as the medication can weaken your immune system, making the vaccine less effective or increasing the risk of infection.

If you are taking any of these medications or are scheduled to receive a live vaccine, talk to your healthcare provider about alternative options. Our telemedicine providers are available to review your medications and help you make informed decisions about your treatment plan.

Anakinra in Pregnancy

Is it safe to take Anakinra when pregnant?

The safety of Anakinra during pregnancy has not been fully established. While animal studies have not shown harm to the fetus, data on its use in pregnant women remains limited. If you are pregnant or planning to become pregnant, it’s crucial to discuss the potential risks and benefits of continuing Anakinra treatment with your healthcare provider. In some cases, managing your condition may take priority over potential risks to the baby. Always consult your provider before making any changes to your medication regimen.

Anakinra while Breastfeeding

Is it safe to take Anakinra while breastfeeding?

There is limited information on whether Anakinra passes into breast milk. However, because Anakinra is a large protein molecule, it is unlikely to be absorbed by the baby in significant amounts through breastfeeding. Still, the decision to use Anakinra while breastfeeding should be made in consultation with your healthcare provider, carefully weighing the benefits of treatment against any potential risks to your baby. Our telemedicine providers are available to help you make an informed decision based on your specific circumstances.

Estimated Cost of Anakinra Medication

The cost of a 30-day supply of Anakinra without insurance can vary. Using a GoodRx coupon, the estimated cost for a 30-day supply of Anakinra (100 mg/day) ranges from approximately $4,000 to $5,000. Prices may differ depending on the pharmacy and location. Be sure to check with your pharmacy for the most accurate pricing, and consider using discount programs or coupons to help reduce the cost.

Possible Alternatives to Anakinra

If Anakinra is not the right treatment for you, several alternative medications and lifestyle changes may help manage your condition. It’s important to discuss any changes to your treatment plan with your healthcare provider before making adjustments. Here are some alternatives based on specific conditions:

1. Rheumatoid arthritis: Alternatives include Methotrexate, Leflunomide (Arava), or Etanercept (Enbrel). Lifestyle changes such as regular exercise, a balanced diet, and stress management can also help alleviate symptoms.
2. Osteoarthritis: Over-the-counter pain relievers like Ibuprofen (Advil) or Acetaminophen (Tylenol) may provide relief. Physical therapy and weight management are also important lifestyle modifications.
3. Still’s disease: Alternatives include Tocilizumab (Actemra) or Canakinumab (Ilaris). Anti-inflammatory diets and regular physical activity may also help manage symptoms.
4. Systemic juvenile idiopathic arthritis:Tocilizumab (Actemra) or Canakinumab (Ilaris) are commonly used alternatives. Physical therapy and maintaining an active lifestyle can also be beneficial.
5. Gout: Medications like Allopurinol (Zyloprim) or Febuxostat (Uloric) can help lower uric acid levels. Dietary changes, such as reducing red meat and alcohol intake, may also help prevent flare-ups.
6. Psoriatic arthritis: Alternatives include Adalimumab (Humira) or Secukinumab (Cosentyx). Regular exercise and maintaining a healthy weight can also help manage symptoms.
7. Ankylosing spondylitis:Infliximab (Remicade) or Secukinumab (Cosentyx) are alternatives. Physical therapy and posture exercises are key lifestyle changes that can improve symptoms.
8. Chronic inflammatory demyelinating polyneuropathy (CIDP): Alternatives include Intravenous immunoglobulin (IVIG) or Plasmapheresis. Physical therapy can also help improve muscle strength and function.
9. Familial Mediterranean fever:Colchicine is the standard treatment. Maintaining a healthy diet and staying hydrated can also help manage symptoms.
10. Cryopyrin-associated periodic syndromes (CAPS): Alternatives include Canakinumab (Ilaris) or Rilonacept (Arcalyst). Regular monitoring and lifestyle adjustments may also help manage symptoms.

Always consult with your healthcare provider before making any changes to your treatment plan. If you are considering an alternative to Anakinra, our telemedicine providers are available to help you explore your options and find the best treatment for your condition.

Recent Updates on Anakinra Research

Recent studies have explored the use of Anakinra in treating conditions beyond its traditional applications, including COVID-19-related hyperinflammation. Some research suggests that Anakinra may help reduce the severity of inflammation in patients with severe COVID-19, though more studies are needed to confirm its effectiveness in this area. Additionally, ongoing research is investigating the long-term safety and efficacy of Anakinra in treating various autoimmune and inflammatory conditions.

It’s important to stay informed about the latest research and discuss any new findings with your healthcare provider. Our telemedicine providers can help you stay up-to-date on the latest treatment options and research developments for your condition.

James Kingsley

Learn More